期刊
DEVELOPMENTAL CELL
卷 43, 期 5, 页码 563-+出版社
CELL PRESS
DOI: 10.1016/j.devcel.2017.11.007
关键词
-
资金
- USC Office of Research
- Norris Medical Library
- California Institute for Regenerative Medicine (CIRM) [RN2-00938]
- Chen Yong Foundation of the Zhongmei Group
- National Science Foundation [CHE-1455306]
- American Cancer Society [IRG-58-007-51]
- NICHD/USC
- Direct For Mathematical & Physical Scien
- Division Of Chemistry [1455306] Funding Source: National Science Foundation
Glycogen synthase kinase 3 (GSK3) plays a central role in diverse cellular processes. GSK3 has two mammalian isozymes, GSK3 alpha and GSK3 beta, whose functions remain ill-defined because of a lack of inhibitors that can distinguish between the two highly homologous isozymes. Here, we show that GSK3 alpha and GSK3 beta can be selectively inhibited in mouse embryonic stem cells (ESCs) using a chemical-genetic approach. Selective inhibition of GSK3b is sufficient to maintain mouse ESC self-renewal, whereas GSK3 alpha inhibition promotes mouse ESC differentiation toward neural lineages. Genome-wide transcriptional analysis reveals that GSK3 alpha and GSK3 beta have distinct sets of downstream targets. Furthermore, selective inhibition of individual GSK3 isozymes yields distinct phenotypes from gene deletion, highlighting the power of the chemical-genetic approach in dissecting kinase catalytic functions from the protein's scaffolding functions. Our study opens new avenues for defining GSK3 isozyme-specific functions in various cellular processes.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据